Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Verotta

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|November 15, 2005
Sample size computations for PK/PD population modelsDongwoo Kang, Janice B Schwartz, Davide Verotta
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2007
A mechanistic model for the sex-specific response to nalbuphine and naloxone in postoperative painSmita Kshirsagar, Robert Gear, Jon Levine, et al.
Computational and Mathematical Methods in Medicine|February 10, 2018
Mathematical Modeling of Biofilm Structures Using COMSTAT DataDavide Verotta, Janus Haagensen, Alfred M Spormann, et al.
British Journal of Clinical Pharmacology|July 7, 2012
Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factorsAdam Frymoyer, Davide Verotta, Pamala Jacobson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2005
Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjectsChantal Csajka, Bruno P Imbimbo, Annalisa Piccinno, et al.
Brain : a Journal of Neurology|March 12, 2004
CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapyMarta Valle, Richard W Price, Annelie Nilsson, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gumMaria Pitsiu, Jean-Michel Gries, Neal Benowitz, et al.
Pharmacotherapy|April 5, 2013
Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermiaAdam Frymoyer, Lina Meng, Sonia L Bonifacio, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 28, 2014
Determination of meropenem in bacterial media by LC-MS/MSLiusheng Huang, Janus Haagensen, Davide Verotta, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 27, 2002
Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimationFranziska Schaedeli, Maria Pitsiu, Neal L Benowitz, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Pharmacokinetics and Pharmacodynamics|November 15, 2005
Sample size computations for PK/PD population modelsDongwoo Kang, Janice B Schwartz, Davide Verotta
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2007
A mechanistic model for the sex-specific response to nalbuphine and naloxone in postoperative painSmita Kshirsagar, Robert Gear, Jon Levine, et al.
Computational and Mathematical Methods in Medicine|February 10, 2018
Mathematical Modeling of Biofilm Structures Using COMSTAT DataDavide Verotta, Janus Haagensen, Alfred M Spormann, et al.
British Journal of Clinical Pharmacology|July 7, 2012
Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factorsAdam Frymoyer, Davide Verotta, Pamala Jacobson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2005
Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjectsChantal Csajka, Bruno P Imbimbo, Annalisa Piccinno, et al.
Brain : a Journal of Neurology|March 12, 2004
CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapyMarta Valle, Richard W Price, Annelie Nilsson, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gumMaria Pitsiu, Jean-Michel Gries, Neal Benowitz, et al.
Pharmacotherapy|April 5, 2013
Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermiaAdam Frymoyer, Lina Meng, Sonia L Bonifacio, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 28, 2014
Determination of meropenem in bacterial media by LC-MS/MSLiusheng Huang, Janus Haagensen, Davide Verotta, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 27, 2002
Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimationFranziska Schaedeli, Maria Pitsiu, Neal L Benowitz, et al.
Pageof 4